AwardedGermanyGoods€70,924,780
Generika-Ersatzkassen 27
- Published
- Published 16 September 2025
- Deadline
- Closed 20 October 2025
Overview
DAK-Gesundheit has awarded framework agreements for active substance-based rebate contracts covering prescription pharmaceuticals for a 24-month period from July 2026 to June 2028, with an estimated value of approximately 70.9 million EUR. The procurement, divided into 9 lots organized by therapeutic groups, was awarded to seven pharmaceutical suppliers: 089Pharm GmbH, Accord Healthcare S.L.U., BG ALIUD/STADAPHARM GbR, BG Hexal 1A Pharma GbR, Micro Labs GmbH, PUREN Pharma GmbH & Co. KG, and Zentiva Pharma GmbH. DAK-Gesundheit conducted this tendering process on behalf of all participating substitute health insurance funds.
Key details
- Country
- Germany
- Status
- Awarded
- Category
- Goods
- Estimated value
- €70,924,780
- Procedure
- Open
- SME suitable
- No
- Published
- 16 September 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- -€9
- Award date
- 1 December 2025
- Contract period
- — → 15 November 2028
- 089Pharm GmbH
- Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH
- BG ALIUD / STADAPHARM GbR
- BG Hexal 1A Pharma GbR
- Micro Labs GmbH
- PUREN Pharma GmbH & Co. KG
- Zentiva Pharma GmbH
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
8 December 2025
Contract Notice
16 September 2025
Contracting authority
DAK-Gesundheit
Procuring entityHamburg, Germany
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.